Search research articles
Contact Us
Filters
Showing results (71-80 of 141) with videos related to
Page
of 15
Sort By:
British Journal of Haematology
|
February 27, 2004
Intravenous (IV) anti-D and IV immunoglobulin achieve acute platelet increases by different mechanisms: modulation of cytokine and platelet responses to IV anti-D by FcgammaRIIa and FcgammaRIIIa polymorphisms
Nichola Cooper, Nancy M Heddle, Masja Haas, et al.
Cancer Research
|
August 6, 2009
Migratory and antigen presentation functions of IFN-producing killer dendritic cells
Nourredine Himoudi, Mengyong Yan, Gerben Bouma, et al.
Advances in Therapy
|
October 27, 2021
Psychometric Evaluation of ITP Life Quality Index (ILQI) in a Global Survey of Patients with Immune Thrombocytopenia
Ricardo Viana, Denise D'Alessio, Laura Grant, et al.
Cytotherapy
|
June 28, 2014
Differential effects of mycophenolate mofetil and cyclosporine A on peripheral blood and cord blood natural killer cells activated with interleukin-2
Sophie Derniame, Juliana Perazzo, Fuiyee Lee, et al.
Therapeutic Advances in Hematology
|
May 17, 2021
Assessment of thrombotic risk during long-term treatment of immune thrombocytopenia with fostamatinib
Nichola Cooper, Ivy Altomare, Mark R Thomas, et al.
Blood Reviews
|
March 18, 2026
Towards achieving immune reset in autoimmune cytopenias: Insights from clinical experiences with B cell depleting therapies
David J Kuter, Sigbjørn Berentsen, Nichola Cooper, et al.
British Journal of Haematology
|
November 18, 2024
Inhibition of FcRn with rozanolixizumab in adults with immune thrombocytopenia: Two randomised, double-blind, placebo-controlled phase 3 studies and their open-label extension
Nichola Cooper, James B Bussel, Maciej Kaźmierczak, et al.
Blood Advances
|
August 24, 2021
Bone marrow remodeling supports hematopoiesis in response to immune thrombocytopenia progression in mice
Oliver J Herd, Gulab Fatima Rani, James P Hewitson, et al.
BMJ Open
|
October 21, 2018
Trial protocol: a multicentre randomised trial of first-line treatment pathways for newly diagnosed immune thrombocytopenia: standard steroid treatment versus combined steroid and mycophenolate. The FLIGHT trial
Julie Pell, Rosemary Greenwood, Jenny Ingram, et al.
British Journal of Haematology
|
January 13, 2021
Fostamatinib is an effective second-line therapy in patients with immune thrombocytopenia
Ralph Boccia, Nichola Cooper, Waleed Ghanima, et al.
Page
of 15
Search research articles
Search
Showing results (71-80 of 141) with videos related to
Sort By:
Page
of 15
British Journal of Haematology
|
February 27, 2004
Intravenous (IV) anti-D and IV immunoglobulin achieve acute platelet increases by different mechanisms: modulation of cytokine and platelet responses to IV anti-D by FcgammaRIIa and FcgammaRIIIa polymorphisms
Nichola Cooper, Nancy M Heddle, Masja Haas, et al.
Cancer Research
|
August 6, 2009
Migratory and antigen presentation functions of IFN-producing killer dendritic cells
Nourredine Himoudi, Mengyong Yan, Gerben Bouma, et al.
Advances in Therapy
|
October 27, 2021
Psychometric Evaluation of ITP Life Quality Index (ILQI) in a Global Survey of Patients with Immune Thrombocytopenia
Ricardo Viana, Denise D'Alessio, Laura Grant, et al.
Cytotherapy
|
June 28, 2014
Differential effects of mycophenolate mofetil and cyclosporine A on peripheral blood and cord blood natural killer cells activated with interleukin-2
Sophie Derniame, Juliana Perazzo, Fuiyee Lee, et al.
Therapeutic Advances in Hematology
|
May 17, 2021
Assessment of thrombotic risk during long-term treatment of immune thrombocytopenia with fostamatinib
Nichola Cooper, Ivy Altomare, Mark R Thomas, et al.
Blood Reviews
|
March 18, 2026
Towards achieving immune reset in autoimmune cytopenias: Insights from clinical experiences with B cell depleting therapies
David J Kuter, Sigbjørn Berentsen, Nichola Cooper, et al.
British Journal of Haematology
|
November 18, 2024
Inhibition of FcRn with rozanolixizumab in adults with immune thrombocytopenia: Two randomised, double-blind, placebo-controlled phase 3 studies and their open-label extension
Nichola Cooper, James B Bussel, Maciej Kaźmierczak, et al.
Blood Advances
|
August 24, 2021
Bone marrow remodeling supports hematopoiesis in response to immune thrombocytopenia progression in mice
Oliver J Herd, Gulab Fatima Rani, James P Hewitson, et al.
BMJ Open
|
October 21, 2018
Trial protocol: a multicentre randomised trial of first-line treatment pathways for newly diagnosed immune thrombocytopenia: standard steroid treatment versus combined steroid and mycophenolate. The FLIGHT trial
Julie Pell, Rosemary Greenwood, Jenny Ingram, et al.
British Journal of Haematology
|
January 13, 2021
Fostamatinib is an effective second-line therapy in patients with immune thrombocytopenia
Ralph Boccia, Nichola Cooper, Waleed Ghanima, et al.
Page
of 15